Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1983 Jul;49(3):423–430.

C3b acceptors on human peripheral blood mononuclear cells; characterization and functional role.

A Erdei, G Füst, J Gyenes, Z Fábry, J Gergely
PMCID: PMC1454288  PMID: 6222965

Abstract

C3b acceptors (C3bAs) of human peripheral blood mononuclear cells (PBMC) reacting with the labile binding site of nascent C3b(C3bx) have been investigated by the immune adherence (IA) test. In non-cellular systems some conventional chemical groups (OH-, NH-2) have been reported to be the target of the covalent binding of C3bx. Thus it should be assumed that every cell can fix C3bx via its labile binding site and C3bAs are barely saturable. Contrary to this expectation, however, normal human PBMC were found to be heterogeneous from this point of view, as 57 +/- 4% of B cells and 21 +/- 2% of Null cells possess C3bAs while T cells do not. C3bAs of human PBMC are saturable and trypsin-sensitive structures. The covalent nature of the C3bx-C3bA interaction has also been proved. Studying the effect of acceptor-bound C3b on the function of other cell-surface structures, the inhibition of the Fc gamma receptor function and the abolishment of the enhancement of pokeweed mitogen-stimulated blastogenesis by immune complexes were found.

Full text

PDF
423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Capel P. J., Groeneboer O., Grosveld G., Pondman K. W. The binding of activated C3 to polysaccharides and immunoglobulins. J Immunol. 1978 Dec;121(6):2566–2572. [PubMed] [Google Scholar]
  2. Dierich M. P., Landen B., Schmitt M. Complement receptor analogous factors in human serum: I. Isolation of a molecule inhibitory for complement dependent rosette formation, its identification as alpha 1-antitrypsin and its functional characterization. Immunobiology. 1979 Aug;156(1-2):153–167. [PubMed] [Google Scholar]
  3. Erdei A., Füst G., Sármay G., Medgyesi G. A., Gergely J. Studies on the mechanism of the complement-mediated inhibition of the Fc and C3 receptors of B lymphocytes. Clin Immunol Immunopathol. 1977 Nov;8(3):367–376. doi: 10.1016/0090-1229(77)90001-0. [DOI] [PubMed] [Google Scholar]
  4. Füst G., Erdei A., Sármay G., Medgyesi G. A., Gergely J. Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes. Clin Immunol Immunopathol. 1976 May;5(3):377–387. doi: 10.1016/0090-1229(76)90047-7. [DOI] [PubMed] [Google Scholar]
  5. Gigli I., Nelson R. A., Jr Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. Exp Cell Res. 1968 Jul;51(1):45–67. doi: 10.1016/0014-4827(68)90158-4. [DOI] [PubMed] [Google Scholar]
  6. Herman J. J., Rosner I. K., Davis A. E., 3rd, Zeiger R. S., Arnaout M. A., Colten H. R. Complement-dependent histaminase release from human granulocytes. J Clin Invest. 1979 Jun;63(6):1195–1202. doi: 10.1172/JCI109414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Law S. K., Levine R. P. Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701–2705. doi: 10.1073/pnas.74.7.2701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Law S. K., Lichtenberg N. A., Levine R. P. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J Immunol. 1979 Sep;123(3):1388–1394. [PubMed] [Google Scholar]
  9. Mann J., O'Brien R., Hostetter M. K., Alper C. A., Rosen F. S., Babior B. M. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway. J Immunol. 1981 Jun;126(6):2370–2372. [PubMed] [Google Scholar]
  10. Medicus R. G., Götze O., Müller-Eberhard H. J. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J Exp Med. 1976 Oct 1;144(4):1076–1093. doi: 10.1084/jem.144.4.1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. NELSON R. A., Jr The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science. 1953 Dec 18;118(3077):733–737. doi: 10.1126/science.118.3077.733. [DOI] [PubMed] [Google Scholar]
  12. Rajnavölgyi E., Füst G., Kulics J., Ember J., Medgyesi G. A., Gergely J. The effect of immune complex composition on complement activation and complement dependent complex release. Immunochemistry. 1978 Dec;15(12):887–894. doi: 10.1016/0161-5890(78)90123-2. [DOI] [PubMed] [Google Scholar]
  13. Ross G. D., Polley M. J., Rabellino E. M., Grey H. M. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med. 1973 Oct 1;138(4):798–811. doi: 10.1084/jem.138.4.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sim E., Sim R. B. Binding of fluid-phase complement components C3 and C3b to human lymphocytes. Biochem J. 1981 Sep 15;198(3):509–518. doi: 10.1042/bj1980509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sim R. B., Twose T. M., Paterson D. S., Sim E. The covalent-binding reaction of complement component C3. Biochem J. 1981 Jan 1;193(1):115–127. doi: 10.1042/bj1930115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tack B. D., Prahl J. W. Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 1976 Oct 5;15(20):4513–4521. doi: 10.1021/bi00665a028. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES